ProfileGDS5678 / 1455697_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 16% 14% 16% 21% 15% 19% 19% 16% 15% 16% 16% 16% 16% 16% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4167216
GSM967853U87-EV human glioblastoma xenograft - Control 22.3550814
GSM967854U87-EV human glioblastoma xenograft - Control 32.3884116
GSM967855U87-EV human glioblastoma xenograft - Control 42.4545721
GSM967856U87-EV human glioblastoma xenograft - Control 52.3283715
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.5274419
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4849619
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.3699916
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.3490415
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.3754516
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.3702616
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.3573516
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.3799716
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.3768916